Literature DB >> 8504787

Anterior, total, and two-stage corpus callosum section: differential and incremental seizure responses.

S S Spencer1, D D Spencer, K Sass, M Westerveld, A Katz, R Mattson.   

Abstract

Published reports suggest that control of generalized seizures is improved by callosotomy but do not necessarily indicate that completion of failed anterior callosotomy is beneficial. We studied 42 patients after anterior callosotomy and 22 after total callosotomy, of whom 14 underwent a two-stage procedure. Cure or marked diminution of seizures was most dramatic for atonic and tonic-clonic seizures after anterior callosotomy (100 and 83%), and for tonic-clonic and tonic seizures after total callosotomy (68 and 57%). For the 14 patients who failed to improve after anterior section and then underwent total section, incremental responses were noted for all seizure types, with cure or marked diminution of partial seizures in 2 of 14 patients, of tonic-clonic seizures in 6 of 10, of tonic seizures in 2 of 4, of atonic seizures in 2 of 5, and of myoclonic seizures in 1 of 1. More than two seizure types, verbal IQ < 80, and diffuse ictal EEG patterns were significantly more common in the anterior callosotomy failures. Total callosotomy can be of benefit when anterior callosotomy fails, especially for persistent tonic-clonic and tonic seizures, and will most often be necessary in patients with diffuse cerebral abnormalities.

Entities:  

Mesh:

Year:  1993        PMID: 8504787     DOI: 10.1111/j.1528-1157.1993.tb02596.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  13 in total

1.  Eyebrow incision with supraorbital trephination for endoscopic corpus callosotomy: a feasibility study.

Authors:  R Shane Tubbs; Matthew D Smyth; George Salter; Kyle Doughty; Jeffrey P Blount
Journal:  Childs Nerv Syst       Date:  2004-01-23       Impact factor: 1.475

Review 2.  Corpus callosotomy in children and the disconnection syndromes: a review.

Authors:  Andrew Jea; Shobhan Vachhrajani; Elysa Widjaja; Daniel Nilsson; Charles Raybaud; Manohar Shroff; James T Rutka
Journal:  Childs Nerv Syst       Date:  2008-03-29       Impact factor: 1.475

3.  When should corpus callosotomy be offered as palliative therapy?

Authors:  Bassel W Abou-Khalil
Journal:  Epilepsy Curr       Date:  2010-01       Impact factor: 7.500

4.  Surgical approaches to treating epilepsy in children.

Authors:  Trupti Jadhav; J Helen Cross
Journal:  Curr Treat Options Neurol       Date:  2012-12       Impact factor: 3.598

5.  Total callosotomy for a case of lissencephaly presenting with West syndrome and generalized seizures.

Authors:  T Kamida; T Maruyama; M Fujiki; H Kobayashi; T Izumi; H Baba
Journal:  Childs Nerv Syst       Date:  2005-01-15       Impact factor: 1.475

6.  Gamma knife radiosurgery for callosotomy in children with drug-resistant epilepsy.

Authors:  Hans Georg Eder; Michael Feichtinger; Tom Pieper; Senta Kurschel; Oskar Schroettner
Journal:  Childs Nerv Syst       Date:  2006-06-13       Impact factor: 1.475

7.  Callosotomy for severe epilepsies with generalized seizures: outcome and prognostic factors.

Authors:  G F Rossi; G Colicchio; E Marchese; A Pompucci
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

Review 8.  Corpus callosotomy versus vagus nerve stimulation for atonic seizures and drop attacks: A systematic review.

Authors:  John D Rolston; Dario J Englot; Doris D Wang; Paul A Garcia; Edward F Chang
Journal:  Epilepsy Behav       Date:  2015-08-03       Impact factor: 2.937

9.  Propagation of epileptiform events across the corpus callosum in a cingulate cortical slice preparation.

Authors:  Jeffrey Walker; Gregory Storch; Bonnie Quach-Wong; Julian Sonnenfeld; Gloster Aaron
Journal:  PLoS One       Date:  2012-02-21       Impact factor: 3.240

10.  Staged total callosotomy for lennox-gastaut syndrome: a case report.

Authors:  Eun Hye Lee; Mi-Sun Yum; Seok-Ho Hong; Jeong-Kyo Lee; Su Jeong You; Tae-Sung Ko
Journal:  J Epilepsy Res       Date:  2011-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.